Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients

Abstract Background Recent studies have reported the importance of high-sensitivity troponin T (hs-cTnT) or skin autofluorescence (AF) as a cardiovascular risk factor. However, little is known about the relationship between these two markers. The aim of this study was to clarify the clinical impact...

Full description

Bibliographic Details
Main Author: Takashi Hitsumoto
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Clinical Hypertension
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40885-017-0076-y
id doaj-580e2830d5514f91bdfa0d793b9388f1
record_format Article
spelling doaj-580e2830d5514f91bdfa0d793b9388f12020-11-25T01:56:13ZengBMCClinical Hypertension2056-59092017-10-012311610.1186/s40885-017-0076-yClinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patientsTakashi Hitsumoto0Hitsumoto Medical ClinicAbstract Background Recent studies have reported the importance of high-sensitivity troponin T (hs-cTnT) or skin autofluorescence (AF) as a cardiovascular risk factor. However, little is known about the relationship between these two markers. The aim of this study was to clarify the clinical impact of skin AF on hs-cTnT in hypertensive patients, from the perspective of primary prevention of cardiovascular events. Methods In total, 457 outpatients on treatment for hypertension [182 men and 275 women; mean (± SD) age, 67 ± 13 y] and with no history of cardiovascular events were enrolled. Hs-cTnT levels and skin AF were measured using commercial devices, and relationships between hs-cTnT levels and various clinical parameters including skin AF were examined. Results Hs-cTnT was detected in 405 (88.6%) patients. Skin AF was significantly higher in patients with detectable hs-cTnT than in those without detectable hs-cTnT [2.6 ± 0.5 arbitrary units (AU) vs. 2.2 ± 0.5 AU, respectively, p < 0.001]. In patients with detectable hs-cTnT, there was a significantly positive correlation between skin AF and Log-hs-cTnT (r = 0.41, p < 0.001). Furthermore, multiple regression analysis revealed that skin AF was the strongest variable associated with Log-hs-cTnT as a subordinate factor (β = 0.30, p < 0.001). Conclusions The results of this study indicate that skin AF is an important determining factor for hs-cTnT elevation in hypertensive patients with no history of cardiovascular events.http://link.springer.com/article/10.1186/s40885-017-0076-ySkin autofluorescenceHigh-sensitivity troponin TOxidative stressArterial stiffnessHypertension
collection DOAJ
language English
format Article
sources DOAJ
author Takashi Hitsumoto
spellingShingle Takashi Hitsumoto
Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
Clinical Hypertension
Skin autofluorescence
High-sensitivity troponin T
Oxidative stress
Arterial stiffness
Hypertension
author_facet Takashi Hitsumoto
author_sort Takashi Hitsumoto
title Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
title_short Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
title_full Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
title_fullStr Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
title_full_unstemmed Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
title_sort clinical impact of skin autofluorescence on high-sensitivity troponin t in hypertensive patients
publisher BMC
series Clinical Hypertension
issn 2056-5909
publishDate 2017-10-01
description Abstract Background Recent studies have reported the importance of high-sensitivity troponin T (hs-cTnT) or skin autofluorescence (AF) as a cardiovascular risk factor. However, little is known about the relationship between these two markers. The aim of this study was to clarify the clinical impact of skin AF on hs-cTnT in hypertensive patients, from the perspective of primary prevention of cardiovascular events. Methods In total, 457 outpatients on treatment for hypertension [182 men and 275 women; mean (± SD) age, 67 ± 13 y] and with no history of cardiovascular events were enrolled. Hs-cTnT levels and skin AF were measured using commercial devices, and relationships between hs-cTnT levels and various clinical parameters including skin AF were examined. Results Hs-cTnT was detected in 405 (88.6%) patients. Skin AF was significantly higher in patients with detectable hs-cTnT than in those without detectable hs-cTnT [2.6 ± 0.5 arbitrary units (AU) vs. 2.2 ± 0.5 AU, respectively, p < 0.001]. In patients with detectable hs-cTnT, there was a significantly positive correlation between skin AF and Log-hs-cTnT (r = 0.41, p < 0.001). Furthermore, multiple regression analysis revealed that skin AF was the strongest variable associated with Log-hs-cTnT as a subordinate factor (β = 0.30, p < 0.001). Conclusions The results of this study indicate that skin AF is an important determining factor for hs-cTnT elevation in hypertensive patients with no history of cardiovascular events.
topic Skin autofluorescence
High-sensitivity troponin T
Oxidative stress
Arterial stiffness
Hypertension
url http://link.springer.com/article/10.1186/s40885-017-0076-y
work_keys_str_mv AT takashihitsumoto clinicalimpactofskinautofluorescenceonhighsensitivitytroponintinhypertensivepatients
_version_ 1724980917248720896